A Study to Evaluate Efficacy and Safety of Epoetin Beta (NeoRecormon®) in Anemic Participants With Breast Cancer Undergoing Chemotherapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
This study will evaluate the efficacy and safety of subcutaneous (SC) epoetin beta in anemic participants with breast cancer undergoing chemotherapy.
Epistemonikos ID: b41ccaa9b7fe8b9253b13c1620e610e7389d8096
First added on: May 13, 2024